CRY2 identified as key regulator in colorectal cancer immunity and survival through multi-omics analysis
A prognostic signature was developed integrating ferroptosis- and lipid metabolism-related genes, highlighting CRY2's role in CRC.
Asset / Drug
Drug and asset intelligence for CRY2 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.